PLx Pharma, Inc. (PLXP) News
Filter PLXP News Items
PLXP News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
PLXP News Highlights
- For PLXP, its 30 day story count is now at 2.
- Over the past 1 day, the trend for PLXP's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
- The most mentioned tickers in articles about PLXP are PLX, DRUG and MG.
Latest PLXP News From Around the Web
Below are the latest news stories about PLX PHARMA INC that investors may wish to consider to help them evaluate PLXP as an investment opportunity.
SHOP Stock Price Prediction: Is Shopify Really Worth $65?Shopify (SHOP) stock is on the move Wednesday following a price target and new rating from JP Morgan analyst Andrew Boone. |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on WednesdayPre-market stock movers are a hot topic on Wednesday as we dive into all of the latest news affecting markets this morning. |
Why Is National CineMedia (NCMI) Stock Up 75% Today?National CineMedia (NCMI) stock is on a wild ride Wednesday morning as investors react to restructuring news and a bankruptcy filing. |
Why Is PLx Pharma (PLXP) Stock Down 32% Today?PLx Pharma (PLXP) stock continues to fall on Wednesday as the company gets closer to being delisted from the Nasdaq Exchange. |
PLx Pharma Inc. Enters into a Stalking Horse Asset Purchase Agreement to Sell VAZALORE® and Substantially All of its AssetsSPARTA, N.J., April 12, 2023 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), is a commercial-stage drug delivery platform technology company focused on its clinically-validated and patent-protected PLxGuard™ and VAZALORE®, an FDA-approved liquid-filled aspirin capsule, available in 81 mg and 325 mg doses. The Company today announced that it entered into a stalking horse asset purchase agreement (the “APA”) with PLx Acquisition Company, LLC, a wholly-owned subsidiary |
NEM Stock Alert: Newmont Sweetens Bid for Newcrest to $19.5 BillionNewmont (NEM) stock is in the news Tuesday after the company made a new offer to acquire Newcrest (NCMGY) for $19.5 billion. |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on TuesdayWe're starting off the day with a breakdown of the biggest pre-market stock movers traders will want to keep an eye on Tuesday! |
Why Is PLx Pharma (PLXP) Stock Down 38% Today?PLx Pharma (PLXP) stock is taking a beating on Tuesday and there's a couple of reasons investors will want to know about its fall. |
Why Is Virgin Orbit (VORB) Stock Down 27% Today?Virgin Orbit (VORB) stock is falling on Tuesday after the space travel company received a delisting notice from the Nasdaq Exchange. |
PLx Pharma Inc. Receives Nasdaq Delisting NoticeSPARTA, N.J., April 11, 2023 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), is a commercial-stage drug delivery platform technology company focused on its clinically-validated and patent-protected PLxGuard™ that has the potential to improve the absorption of many drugs currently on the market and to reduce the risk of stomach injury associated with certain drugs. The Company had previously announced that on October 3, 2022, it was notified by the Listing Qualificati |